TegoScience Inc. (KOSDAQ:191420)
South Korea
· Delayed Price · Currency is KRW 12,920
+180 (1.41%)
At close: Mar 6, 2026
TegoScience Company Description
TegoScience Inc., a biotechnology-based cosmetics company, engages in the production of various skin cell therapy products originating from human epithelial cells in South Korea.
The company offers Holoderm, a commercialized cultured skin autograft; Kaloderm, an allogeneic cell therapy product for healing wounds; Rosmir, a fibroblast cell therapy; and Neoderm, a three-dimensionally cultured skin model.
It also provides KCM for skin regeneration effect; Chemotide, a single-chain human peptide; contract research services, such as biologics quality control services and histology services; and SkinBank, an insurance for cells.
The company was founded in 2001 and is headquartered in Seoul, South Korea.
TegoScience Inc.
| Country | South Korea |
| Founded | 2001 |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | Saewha Jeon |
Contact Details
Address: 93, Magokjungang 8-ro Seoul South Korea | |
| Phone | 82 2 818 2900 |
| Website | tegoscience.com |
Stock Details
| Ticker Symbol | 191420 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Saewha Jeon | Chief Executive Officer |
| Yun Chung | Chief Financial Officer |